Enterprise Therapeutics
Brighton, GB · 2 known investors
Enterprise Therapeutics is a drug discovery company developing therapies for respiratory diseases such as cystic fibrosis, asthma, and COPD. Its research targets the underlying mechanisms of mucus congestion in the lungs to reduce lung infections and improve patient quality of life.
Founders & leadership
JF
John FordCo-founder
MG
Martin GoslingFounder
Investors · 2
Competitors · 2
by search overlapAtea Pharmaceuticals6 shared keywordsAtea is a clinical-stage biopharmaceutical company developing oral direct-acting antiviral therapies for single-stranded RNA viruses, currently focused on a bemnifosbuvir and ruzasvir regimen in Phase 3 development for hepatitis C virus (HCV). Its work spans antiviral drug discovery, medicinal chemistry, biology, and virology.
Doximity6 shared keywordsDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.
Companies competing with Enterprise Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Enterprise Therapeutics do?
- Enterprise Therapeutics is a drug discovery company developing therapies for respiratory diseases such as cystic fibrosis, asthma, and COPD. Its research targets the underlying mechanisms of mucus congestion in the lungs to reduce lung infections and improve patient quality of life.
- Who founded Enterprise Therapeutics?
- Enterprise Therapeutics was founded by John Ford.
- Who are Enterprise Therapeutics's investors?
- Enterprise Therapeutics's investors include Epidarex Capital, Versant Ventures.
- Where is Enterprise Therapeutics headquartered?
- Enterprise Therapeutics is headquartered in Brighton, GB.